Influence of high serum alpha fetoprotein on patients with gastric cancer

Ming-Yao Chen, Wen-Liang Fang, Kuo-Hung Huang, Yu-Hsin Lai, Hwai-Jeng Lin

Research output: Book/ReportBook

Abstract

Backgrounds: Patients with alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC) have a high incidence of liver metastasis and poor prognosis. However, the clinical manifestation of AFPGC remains controversial. Methods: We enrolled patients who, before surgery, had gastric cancer with serum AFP levels of >100 ng/mL (n = 30) and of ≦ 20 ng/mL (n = 1236). Clinical manifestations were compared between these two groups. Results: Compared with in the AFP > 100 group, early gastric cancer was more frequent (30.1% vs.0%) and advanced gastric cancer was less frequent (69.9% vs. 100%) in the AFP ≦ 20 ng/mL group (p < 0.001). Moreover, the incidence of liver and lymph node metastases was lower in the AFP ≦ 20 ng/mL group than in the AFP > 100 ng/mL group (4.4% vs. 43.3%, p < 0.001 and 60.7% vs. 93.3%,p < 0.001, respectively). More patients had stage IV AFPGC in the AFP > 100 ng/mL group than in the ≦ 20 ng/mL group (66.7% vs 27.1%, p < 0.001). Furthermore, fewer patients underwent curative surgery in the AFP > 100 ng/mL group (6.7% vs 37.9%, p < 0.001). More patients in the AFP > 100 ng/mL group died because of gastric cancer (66.7% vs 27.1%, p <0.0001).Conclusions: Patients with very high serum AFP levels have a high incidence of liver and lymph node metastases and extremely poor prognosis.
Original languageEnglish
Number of pages4
Volume4
DOIs
Publication statusPublished - Jun 1 2017

Cite this

Influence of high serum alpha fetoprotein on patients with gastric cancer. / Chen, Ming-Yao; Fang, Wen-Liang; Huang, Kuo-Hung; Lai, Yu-Hsin; Lin, Hwai-Jeng.

2017. 4 p.

Research output: Book/ReportBook

@book{b8ab944c6ef740e790d9fcc610574d11,
title = "Influence of high serum alpha fetoprotein on patients with gastric cancer",
abstract = "Backgrounds: Patients with alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC) have a high incidence of liver metastasis and poor prognosis. However, the clinical manifestation of AFPGC remains controversial. Methods: We enrolled patients who, before surgery, had gastric cancer with serum AFP levels of >100 ng/mL (n = 30) and of ≦ 20 ng/mL (n = 1236). Clinical manifestations were compared between these two groups. Results: Compared with in the AFP > 100 group, early gastric cancer was more frequent (30.1{\%} vs.0{\%}) and advanced gastric cancer was less frequent (69.9{\%} vs. 100{\%}) in the AFP ≦ 20 ng/mL group (p < 0.001). Moreover, the incidence of liver and lymph node metastases was lower in the AFP ≦ 20 ng/mL group than in the AFP > 100 ng/mL group (4.4{\%} vs. 43.3{\%}, p < 0.001 and 60.7{\%} vs. 93.3{\%},p < 0.001, respectively). More patients had stage IV AFPGC in the AFP > 100 ng/mL group than in the ≦ 20 ng/mL group (66.7{\%} vs 27.1{\%}, p < 0.001). Furthermore, fewer patients underwent curative surgery in the AFP > 100 ng/mL group (6.7{\%} vs 37.9{\%}, p < 0.001). More patients in the AFP > 100 ng/mL group died because of gastric cancer (66.7{\%} vs 27.1{\%}, p <0.0001).Conclusions: Patients with very high serum AFP levels have a high incidence of liver and lymph node metastases and extremely poor prognosis.",
keywords = "Gastric cancer, Alpha fetoprotein, Metastasis, Operation",
author = "Ming-Yao Chen and Wen-Liang Fang and Kuo-Hung Huang and Yu-Hsin Lai and Hwai-Jeng Lin",
year = "2017",
month = "6",
day = "1",
doi = "10.1002/aid2.12050",
language = "English",
volume = "4",

}

TY - BOOK

T1 - Influence of high serum alpha fetoprotein on patients with gastric cancer

AU - Chen, Ming-Yao

AU - Fang, Wen-Liang

AU - Huang, Kuo-Hung

AU - Lai, Yu-Hsin

AU - Lin, Hwai-Jeng

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Backgrounds: Patients with alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC) have a high incidence of liver metastasis and poor prognosis. However, the clinical manifestation of AFPGC remains controversial. Methods: We enrolled patients who, before surgery, had gastric cancer with serum AFP levels of >100 ng/mL (n = 30) and of ≦ 20 ng/mL (n = 1236). Clinical manifestations were compared between these two groups. Results: Compared with in the AFP > 100 group, early gastric cancer was more frequent (30.1% vs.0%) and advanced gastric cancer was less frequent (69.9% vs. 100%) in the AFP ≦ 20 ng/mL group (p < 0.001). Moreover, the incidence of liver and lymph node metastases was lower in the AFP ≦ 20 ng/mL group than in the AFP > 100 ng/mL group (4.4% vs. 43.3%, p < 0.001 and 60.7% vs. 93.3%,p < 0.001, respectively). More patients had stage IV AFPGC in the AFP > 100 ng/mL group than in the ≦ 20 ng/mL group (66.7% vs 27.1%, p < 0.001). Furthermore, fewer patients underwent curative surgery in the AFP > 100 ng/mL group (6.7% vs 37.9%, p < 0.001). More patients in the AFP > 100 ng/mL group died because of gastric cancer (66.7% vs 27.1%, p <0.0001).Conclusions: Patients with very high serum AFP levels have a high incidence of liver and lymph node metastases and extremely poor prognosis.

AB - Backgrounds: Patients with alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC) have a high incidence of liver metastasis and poor prognosis. However, the clinical manifestation of AFPGC remains controversial. Methods: We enrolled patients who, before surgery, had gastric cancer with serum AFP levels of >100 ng/mL (n = 30) and of ≦ 20 ng/mL (n = 1236). Clinical manifestations were compared between these two groups. Results: Compared with in the AFP > 100 group, early gastric cancer was more frequent (30.1% vs.0%) and advanced gastric cancer was less frequent (69.9% vs. 100%) in the AFP ≦ 20 ng/mL group (p < 0.001). Moreover, the incidence of liver and lymph node metastases was lower in the AFP ≦ 20 ng/mL group than in the AFP > 100 ng/mL group (4.4% vs. 43.3%, p < 0.001 and 60.7% vs. 93.3%,p < 0.001, respectively). More patients had stage IV AFPGC in the AFP > 100 ng/mL group than in the ≦ 20 ng/mL group (66.7% vs 27.1%, p < 0.001). Furthermore, fewer patients underwent curative surgery in the AFP > 100 ng/mL group (6.7% vs 37.9%, p < 0.001). More patients in the AFP > 100 ng/mL group died because of gastric cancer (66.7% vs 27.1%, p <0.0001).Conclusions: Patients with very high serum AFP levels have a high incidence of liver and lymph node metastases and extremely poor prognosis.

KW - Gastric cancer

KW - Alpha fetoprotein

KW - Metastasis

KW - Operation

U2 - 10.1002/aid2.12050

DO - 10.1002/aid2.12050

M3 - Book

VL - 4

BT - Influence of high serum alpha fetoprotein on patients with gastric cancer

ER -